Synthesis, characterization and investigation of AChE and BuChE inhibitory activity of 1-alkyl-4-[(5,6-dimethoxy-1-indanone-2-yl)methylene]pyridinium halide derivatives

  • Hanieh Farrokhi
  • Sakineh Mozaffarnia
  • Keshvar Rahimpour
  • Mohammad Reza RashidiEmail author
  • Reza Teimuri-MofradEmail author
Original Paper


The design, synthesis and characterization of a series of 1-alkyl-4-[(5,6-dimethoxy-1-indanone-2-yl)methylene]pyridinium halide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors for the treatment of Alzheimer’s disease were reported. The strategy for this synthesis was based on aldol condensation reaction between 4-pyridinecarboxaldehyde with 5,6-dimethoxy-1-indanone in the presence of NaOH in EtOH-H2O solution as the first step and N-alkylation reaction of the produced 5,6-dimethoxy-2-[(pyridin-4-yl)methylene]-1-indanone with various alkyl halides (R–X) in the second step. This reaction was carried out under reflux temperature in polar aprotic solvents such as acetone or acetonitrile. 1H and 13C NMR and FTIR spectroscopy along with CHN analysis were used to confirm the structure of our synthesized compounds. Biological activities including acetylcholinesterase and butyrylcholinesterase (BuChE) inhibitions for synthesized compounds were tested using the Ellman method. The results were compared with donepezil and galantamine, and among the synthesized compounds, the highest inhibitory activity with BuChE IC50 = 0.55 μM was observed.

Graphic abstract


1-Indanone Acetylcholinesterase (AChE) Butyrylcholinesterase (BuChE) Enzyme inhibitor 



This project was financially supported by a grant from Deputy for Research and Technology of Iranian Ministry of Health and Medical Education. The authors would like to acknowledge the financial support from Tabriz University of medical sciences and the University of Tabriz.


  1. 1.
    N. Chitranshi, S. Gupta, P.K. Tripathi, P.K. Seth, Med. Chem. Res. 22, 2328 (2013)CrossRefGoogle Scholar
  2. 2.
    M.A. Ali, M.S. Yar, M.Z. Hasan, M.J. Ahsan, S. Pandian, Bioorganic Med. Chem. Lett. 19, 5075 (2009)CrossRefGoogle Scholar
  3. 3.
    F.C. Meng, F. Mao, W.J. Shan, F. Qin, L. Huang, X.S. Li, Bioorganic Med. Chem. Lett. 22, 4462 (2012)CrossRefGoogle Scholar
  4. 4.
    A. Saxena, W. Sun, C. Luo, T.M. Myers, I. Koplovitz, D.E. Lenz et al., J. Mol. Neurosci. 30(1–2), 145 (2006)CrossRefGoogle Scholar
  5. 5.
    M.G. Cardozo, T. Kawai, Y. Iimura, H. Sugimoto, Y. Yamanishi, A.J. Hopfinger, J. Med. Chem. 35, 590 (1992)CrossRefGoogle Scholar
  6. 6.
    L. Peauger, R. Azzouz, V. Gembus, M.L. Tintas, J. Sopková-de Oliveira Santos, P. Bohn, C. Papamicaël, V. Levacher, J. Med. Chem. 60(13), 5909 (2017)CrossRefGoogle Scholar
  7. 7.
    H. Sugimoto, Y. Iimura, Y. Yamanishi, K. Yamatsu, Bioorganic Med. Chem. Lett. 2(8), 871 (1992)CrossRefGoogle Scholar
  8. 8.
    S. Hamulakova, L. Janovec, M. Hrabinova, K. Spilovska, J. Korabecny, P. Kristian, K. Kuca, J. Imrich, J. Med. Chem. 57(16), 7073 (2014)CrossRefGoogle Scholar
  9. 9.
    P. Camps, X. Formosa, C. Galdeano, T. Gómez, D. Muñoz-Torrero, L. Ramírez, E. Viayna, E. Gómez, N. Isambert, R. Lavilla, A. Badia, Chem. Biol. Interact. 187(1–3), 411 (2010)CrossRefGoogle Scholar
  10. 10.
    K.C. Miles, C.C. Le, J.P. Stambuli, Chem. Eur. J. 20(36), 11336 (2014)CrossRefGoogle Scholar
  11. 11.
    J.K. Clark, P. Cowley, A.W. Muir, R. Palin, E. Pow, A.B. Prosser, R. Taylor, M.G. Zhang, Bioorganic Med. Chem. Lett. 12(18), 2565 (2002)CrossRefGoogle Scholar
  12. 12.
    H. Sugimoto, Y. Yamanishi, Y. Iimura, Y. Kawakami, Curr. Med. Chem. 7, 303 (2000)CrossRefGoogle Scholar
  13. 13.
    M.H. Tabert, X. Liu, R.L. Doty, M. Serby, D. Zamora, G.H. Pelton, K. Marder, M.W. Albers, Y. Stern, D.P. Devanand, Ann. Neurol. 58, 155 (2005)CrossRefGoogle Scholar
  14. 14.
    M. Pohanka, Biomed. Pap. Med. Fac. Palacky Univ. Olomouc 155, 3 (2011)CrossRefGoogle Scholar
  15. 15.
    B. Lantaño, J.M. Aguirre, E.V. Drago, M. Bollini, D.J. de la Faba, J.D. Mufato, Synth. Commun. 47(23), 2202 (2017)CrossRefGoogle Scholar
  16. 16.
    A. Shaabani, A. Sarvary, S. Keshipour, A.H. Rezayan, R. Ghadari, Tetrahedron 66(10), 1911 (2010)CrossRefGoogle Scholar
  17. 17.
    M.H. Chahma, C. Combellas, A. Thiebault, Synthesis 2004(04), 517 (2004)CrossRefGoogle Scholar
  18. 18.
    R.P. Singh, R.D. Verma, D.T. Meshri, J.N. Shreeve, Angew. Chem. 45(22), 3584 (2006)CrossRefGoogle Scholar
  19. 19.
    A.S. Kiselyov, Tetrahedron Lett. 46(26), 4487 (2005)CrossRefGoogle Scholar
  20. 20.
    S. Keshipour, S. Shaabani, A. Shaabani, Tetrahedron Lett. 53(52), 7085 (2012)CrossRefGoogle Scholar
  21. 21.
    S. Keshipour, A. Shaabani, M. Pedarpour, A. Sarvary, Res. Chem. Intermediat. 40(1), 149 (2014)CrossRefGoogle Scholar
  22. 22.
    J.S. Lan, T. Zhang, Y. Liu, J. Yang, S.S. Xie, J. Liu, Y. Ding, Eur. J. Med. Chem. 133, 184 (2017)CrossRefGoogle Scholar
  23. 23.
    G.L. Ellman, K.D. Courtney, V. Andres Jr., R.M. Fesrtherstone, Biochem. Pharmacol. 7, 88 (1961)Google Scholar
  24. 24.
    G. Karimi, M. Iranshahi, F. Hosseinalizadeh, B. Riahi, A. Sahebkar, Pharmacology 1, 566 (2010)Google Scholar

Copyright information

© Iranian Chemical Society 2019

Authors and Affiliations

  1. 1.Department of Organic and Biochemistry, Faculty of ChemistryUniversity of TabrizTabrizIran
  2. 2.Research Center for Pharmaceutical NanotechnologyTabriz University of Medical SciencesTabrizIran

Personalised recommendations